Today: 10 June 2026
Browse Category

NASDAQ:OCUL 6 December 2025 - 30 May 2026

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

Ocular Therapeutix shares surged 28.1% to $16.11 on December 8, hitting a new 52-week high after the company announced plans to file an accelerated NDA for its retina drug AXPAXLI in wet AMD, based on a single Phase 3 trial. Trading volume spiked, and year-to-date gains reached about 44%. The company aims to submit the NDA after year-one SOL-1 trial data in Q1 2026.
9 December 2025

Stock Market Today

  • Technip Energies (ENXTPA:TE) Stock Shows Short-Term Weakness Amid Strong Long-Term Gains
    June 10, 2026, 8:48 AM EDT. Technip Energies (ENXTPA:TE) shares fell about 2% over the past day and week, extending a roughly 7% drop this month. Despite near-term weakness, the stock is flat over three months and up modestly over one year, with a strong total return exceeding 100% over five years. The French engineering and technology firm reported €7.17 billion in annual revenue and €346 million net income, growing at single to low double digits. Market analysts value the stock at €44.24 versus the last close of €34.40, suggesting it is about 22% undervalued. Growth drivers include rising decarbonization orders, boosted by global net zero commitments and clean energy incentives. Risks remain around LNG and hydrocarbon projects, plus policy or funding delays for key decarbonization initiatives.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Shares Fall Again; Microsoft AI Cloud Agreement Still in Focus

10 June 2026
IREN plunged 8.73% to $54.02 Tuesday and slid another 3.72% premarket as investors weighed Wall Street’s bullish calls on its AI cloud buildout against a tech and crypto selloff; the stock’s fate now hinges on IREN’s ability to deliver Microsoft- and Nvidia-linked AI infrastructure on schedule, with the Microsoft contract at risk if timelines slip.
Go toTop